CDC25B and melanoma: These observations are consistent with a previous report [32] showing that cAMP signaling downstream of MC1R impairs melanoma cell growth by inhibiting the activity of cdc25B, a phosphatase that removes the inhibitory phosphorylation of cyclin-dependent kinase 1 (CDK1) to promote the cell cycle’s progression to mitosis.